Hashimoto’s thyroiditis both promotes and protects against papillary thyroid cancer
Frontiers in Endocrinology · 2026
DOI: 10.3389/fendo.2026.1898677 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Endocrinology, 2026. Verfasst von Xin Lin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, The Third Affiliated Hospital of Southern Medical University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Hashimoto Disease, Thyroid Neoplasms, Thyroid Cancer, Papillary. Die Arbeit nennt 175 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The growing body of evidence suggests a complicated association between papillary thyroid cancer (PTC) and Hashimoto’s thyroiditis (HT). Although HT is a major risk factor for PTC development, it is also associated with improved patient outcomes. However, the molecular mechanisms between these two diseases remain unclear. This narrative review summarizes clinical evidence that connects HT with PTC and examines how these two conditions interact. It explores the involvement of CD4 + T-cell subsets, regulatory T cells, CD8 + T cells, tumor-associated macrophages, and key immunological molecules in remodeling the tumor immune microenvironment (TIME) during HT. We also discuss the contributions of genetic predisposition, environmental factors, thyroid-stimulating hormone and autoantibodies, non-coding RNA regulatory networks, and the gut microbiota to the relationship between the two diseases. Further research is needed to fill the gaps in our understanding of HT and PTC linkages, aiming to provide a theoretical foundation for developing personalized therapies that target the TIME.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, The Third Affiliated Hospital of Southern Medical University, Guangzhou, Guangdong, China.
- Department of Endocrinology and Metabolism, The Eighth Affiliated Hospital of Southern Medical University (The First People's Hospital of Shunde), Foshan, Guangdong, China.
- GuangDong Engineering Technology Research Center of Metabolic Disorders Interdisciplinary Precision Prevention and Digital Healthcare, The Eighth Affiliated Hospital of Southern Medical University (The First People's Ho…
Zitieren
APA
Lin, X., Chen, Z., Song, D., & Shen, J. (2026). Hashimoto’s thyroiditis both promotes and protects against papillary thyroid cancer. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2026.1898677
Vancouver
Lin X, Chen Z, Song D, Shen J. Hashimoto’s thyroiditis both promotes and protects against papillary thyroid cancer. Frontiers in Endocrinology. 2026. doi:10.3389/fendo.2026.1898677
BibTeX
@article{Lin2026,
author = {Lin, Xin and Chen, Zhi and Song, Dandan and Shen, Jie},
title = {Hashimoto’s thyroiditis both promotes and protects against papillary thyroid cancer},
journal = {Frontiers in Endocrinology},
year = {2026},
doi = {10.3389/fendo.2026.1898677}
}
EUVIMED